| Announcement of Full-Cycle Innovation Strategies and Latest Trends in the Pharmaceutical, Biotech, and Medical Device Fields
| Industry Experts to Share Insights at the 3rd '2024 JNPMEDI CONNECT' on Friday, November 22
JNPMEDI (CEO Kwunho Jeong) announced on the 24th that it will host the 3rd ‘2024 JNPMEDI CONNECT’ at The Plaza Hotel Grand Ballroom in Seoul on this following Friday, November 22nd.
This year, JNPMEDI expanded its business scope to include investment, contract research organization (CRO) services, and commercialization consulting for pharmaceutical, biotech, and medical device companies, based on its clinical trial data platform, Maven Clinical Cloud. These efforts have further solidified the company's position as a Life Science RDC (Research, Development, and Commercialization) company. The event will gather industry experts to share the latest trends, experiences, and insights across each stage of RDC.
The event’s academic organizing committee is chaired by Dr. Ilseop Lee, Director of the Future Medicine Research Institute at Bundang CHA Hospital, and includes prominent figures such as Dahee Lee, CEO of Seoul CRO, Hanlim Moon, CEO of MediRama, and Hyeongjin Jeong, Executive Director at Janssen Korea. Additionally, experts from various fields, including Kyunghwa Heo, CEO of KIMCo, and Daeyoung Jung, Senior Manager at Rigachem Bio, will participate as speakers and panelists to engage in in-depth discussions.
JNPMEDI CEO Kwunho Jeong stated, “As we host the 3rd '2024 JNPMEDI CONNECT' this year, the event goes beyond mere information exchange, offering an in-depth exploration of practical strategies and the latest technologies in the RDC field. It will provide valuable insights to industry stakeholders. By systematically addressing key challenges and solutions at each stage, the event will promote innovation throughout the industry and create opportunities for new collaborations.”
The '2024 JNPMEDI CONNECT' will be held on Friday, November 22, at The Plaza Hotel Grand Ballroom in Seoul, and is open to professionals from the pharmaceutical, biotech, and medical device industries, as well as anyone interested in related fields. Event details and pre-registration are available on the JNPMEDI CONNECT website, with pre-registered participants eligible for a lucky draw event on the day of the event.
✔ JNPMEDI CONNECT Pre-Registration Link
https://connect.jnpmedi.com
| Announcement of Full-Cycle Innovation Strategies and Latest Trends in the Pharmaceutical, Biotech, and Medical Device Fields
| Industry Experts to Share Insights at the 3rd '2024 JNPMEDI CONNECT' on Friday, November 22
JNPMEDI (CEO Kwunho Jeong) announced on the 24th that it will host the 3rd ‘2024 JNPMEDI CONNECT’ at The Plaza Hotel Grand Ballroom in Seoul on this following Friday, November 22nd.
This year, JNPMEDI expanded its business scope to include investment, contract research organization (CRO) services, and commercialization consulting for pharmaceutical, biotech, and medical device companies, based on its clinical trial data platform, Maven Clinical Cloud. These efforts have further solidified the company's position as a Life Science RDC (Research, Development, and Commercialization) company. The event will gather industry experts to share the latest trends, experiences, and insights across each stage of RDC.
The event’s academic organizing committee is chaired by Dr. Ilseop Lee, Director of the Future Medicine Research Institute at Bundang CHA Hospital, and includes prominent figures such as Dahee Lee, CEO of Seoul CRO, Hanlim Moon, CEO of MediRama, and Hyeongjin Jeong, Executive Director at Janssen Korea. Additionally, experts from various fields, including Kyunghwa Heo, CEO of KIMCo, and Daeyoung Jung, Senior Manager at Rigachem Bio, will participate as speakers and panelists to engage in in-depth discussions.
JNPMEDI CEO Kwunho Jeong stated, “As we host the 3rd '2024 JNPMEDI CONNECT' this year, the event goes beyond mere information exchange, offering an in-depth exploration of practical strategies and the latest technologies in the RDC field. It will provide valuable insights to industry stakeholders. By systematically addressing key challenges and solutions at each stage, the event will promote innovation throughout the industry and create opportunities for new collaborations.”
The '2024 JNPMEDI CONNECT' will be held on Friday, November 22, at The Plaza Hotel Grand Ballroom in Seoul, and is open to professionals from the pharmaceutical, biotech, and medical device industries, as well as anyone interested in related fields. Event details and pre-registration are available on the JNPMEDI CONNECT website, with pre-registered participants eligible for a lucky draw event on the day of the event.
✔ JNPMEDI CONNECT Pre-Registration Link
https://connect.jnpmedi.com